Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Omada Health (OMDA) Gains from Investment Securities (2024 - 2026)

Omada Health's Gains from Investment Securities history spans 2 years, with the latest figure at -$1.7 million for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities fell 695.83% to -$1.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$987000.0, a N/A change, with the full-year FY2025 number at -$251000.0, down 15.14% from a year prior.
  • Gains from Investment Securities hit -$1.7 million in Q4 2025 for Omada Health, down from $212000.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for OMDA hit a ceiling of $736000.0 in Q2 2025 and a floor of -$1.7 million in Q4 2025.